ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008